Yes, to both Painkiller and Jaluma.
And yes, absolutely toddler revenue-wise when compared to NEA.
But some of these contracts being signed now are $240,000 p.a., and that's just for starters. As they add more users, this could scale much faster and bigger than the market is currently pricing in.
Especially as many of the target market verticals are also scaling at pace.
Not getting carried away, just interested to see how it evolves.
3dp chart, page-47
-
- There are more pages in this discussion • 3,632 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
